Sponsor:
Boston Scientific Corporation
Code:
NCT01719055
Conditions
Pain
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
neurostimulation system
Brief summary:
Conditions
Pain
Study ID
NCT01719055
Start date
Nov 19, 2012
Status verified date
Aug, 2026
Completion date
May, 2035
Anticipated
Primary completion date
May, 2035
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
4800 participants
Anticipated
Arms
Boston Scientific SCS Systems
Interventions
neurostimulation system
Central contacts
Locations
Denver Back Pain Specialists
Recruiting
Greenwood Village, Colorado, United States, 80111
Contacts
Orlando Health Neuroscience Institute, Inc
Recruiting
Clermont, Florida, United States, 34711
Contacts
South Lake Pain Institute, Inc
Recruiting
Clermont, Florida, United States, 34711
Contacts
University of Florida Shands Hospital
Recruiting
Gainesville, Florida, United States, 32608
Contacts
Ochsner Clinic Foundation
Recruiting
New Orleans, Louisiana, United States, 70115
Contacts
Willis-Knighton River Cities Clinical Research Center
Recruiting
Shreveport, Louisiana, United States, 71105
Contacts
Brigham and Women's Hospital
Recruiting
Boston, Massachusetts, United States, 02115
Contacts
Montefiore Medical Center
Recruiting
The Bronx, New York, United States, 10461
Contacts
Pacific Sports and Spine, LLC
Recruiting
Eugene, Oregon, United States, 97401
Contacts
Fox Chase Pain Management
Recruiting
Trevose, Pennsylvania, United States, 19053
Contacts
PCPMG Clinical Research Unit, LLC
Recruiting
Greenville, South Carolina, United States, 29601
Contacts
Institute of Precision Pain Medicine
Recruiting
Corpus Christi, Texas, United States, 78414
Contacts
Hopital de Enfant-Jesus
Recruiting
Québec, Canada
Contacts
Regina General Hospital
Recruiting
Regina, Canada
Contacts
Sponsor
Boston Scientific Corporation
Last update posted
Aug 11, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Boston Scientific Corporation on 2026-08-11.